Evidence map›Paper›PMID 40071064›Full record

ArticleKidney medicine2025

Associations of Serum Amphiregulin Levels With Kidney Failure and Mortality: The Chronic Renal Insufficiency Cohort (CRIC).

Insa M Schmidt, Eirini Kefalogianni, Runqi Zhao, Ashish Verma, Venkata Sabbisetti, Mahboob Rahman, Nishigandha Pradhan, Anand Srivastava, Jiang He, Jing Chen and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Amphiregulin in Fibrotic Diseases and Cancer.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Insa M SchmidtSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.
Eirini KefalogianniDivision of Rheumatology, Department of Medicine, Washington University School ofMedicine, St. Louis, MO.
Runqi ZhaoSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.
Ashish VermaSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.
Venkata SabbisettiRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Mahboob RahmanDepartment of Medicine, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH.
Nishigandha PradhanDepartment of Medicine, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH.
Anand SrivastavaDivision of Nephrology, University of Illinois Chicago, Chicago, IL.
Jiang HeDepartment of Epidemiology and Medicine, Tulane University School of Public Health and Tropical Medicine, and Tulane University School of Medicine, New Orleans, LA.
Jing ChenDepartment of Epidemiology and Medicine, Tulane University School of Public Health and Tropical Medicine, and Tulane University School of Medicine, New Orleans, LA.
Sushrut S WaikarSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.
Andreas HerrlichDivision of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
CRIC Study Investigators

Funding

Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
Biomarkers of Kidney PathologyR01DK093574 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI WAIKAR, SUSHRUT S. · 2012 to 2015
$2.4M
Role of Amphiregulin in kidney fibrosisR01DK121200 · NIDDK · WASHINGTON UNIVERSITY · PI HERRLICH, ANDREAS · 2019 to 2023
$2.1M
Functional MRI to Identify High-risk CKD PhenotypesR01DK139321 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Anand Srivastava · 2025 to 2026
$1.5M
Non-Invasive Imaging Biomarkers to Identify a High-Risk Chronic Kidney Disease PhenotypeK23DK120811 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SRIVASTAVA, ANAND · 2020 to 2024
$1.0M
NIDDK NIH HHS K23 DK120811NIDDK NIH HHS R01 DK093574NIDDK NIH HHS R01 DK121200NIDDK NIH HHS R01 DK139321NIDDK NIH HHS U24 DK060990
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40071064
PMCPMC11894294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.